Table of Contents
Neurodegenerative diseases such as Alzheimer’s disease are characterized by the progressive loss of neuronal structure and function. Recent research has highlighted the significant role that gene expression alterations play in the development and progression of these disorders.
Understanding Gene Expression
Gene expression refers to the process by which information from a gene is used to synthesize functional gene products, typically proteins. Changes in this process can lead to abnormal protein production, which may contribute to disease pathology.
Gene Expression Changes in Alzheimer’s Disease
In Alzheimer’s disease, numerous studies have identified altered expression levels of genes involved in various cellular processes, including amyloid precursor protein processing, tau protein regulation, inflammation, and synaptic function.
Key Genes Affected
- APP: Increased expression can lead to excess amyloid-beta production, forming plaques characteristic of Alzheimer’s.
- MAPT: Changes in tau gene expression influence neurofibrillary tangle formation.
- CLU: Variations affect lipid metabolism and amyloid clearance.
- TREM2: Altered expression impacts microglial response and inflammation.
Implications for Treatment
Understanding gene expression alterations opens new avenues for therapeutic interventions. Targeting specific genes or pathways may help slow disease progression or alleviate symptoms. For example, gene therapy and RNA-based treatments are promising areas of research.
Future Directions
Ongoing research aims to map the complete gene expression landscape in neurodegenerative diseases. Advances in technologies like single-cell RNA sequencing are providing detailed insights, which could lead to personalized medicine approaches.